UA111731C2 - Стабілізована композиція, яка містить антитіло до рецептора інтерлейкіну-4 (іl-4r), варіанти - Google Patents
Стабілізована композиція, яка містить антитіло до рецептора інтерлейкіну-4 (іl-4r), варіантиInfo
- Publication number
- UA111731C2 UA111731C2 UAA201305598A UAA201305598A UA111731C2 UA 111731 C2 UA111731 C2 UA 111731C2 UA A201305598 A UAA201305598 A UA A201305598A UA A201305598 A UAA201305598 A UA A201305598A UA 111731 C2 UA111731 C2 UA 111731C2
- Authority
- UA
- Ukraine
- Prior art keywords
- receptor
- composition containing
- interlaykin
- options
- containing antibody
- Prior art date
Links
- 108040006852 interleukin-4 receptor activity proteins Proteins 0.000 title 1
- 101001033312 Homo sapiens Interleukin-4 receptor subunit alpha Proteins 0.000 abstract 2
- 125000003275 alpha amino acid group Chemical group 0.000 abstract 2
- 102000054663 human IL4R Human genes 0.000 abstract 2
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 abstract 1
- 239000004475 Arginine Substances 0.000 abstract 1
- HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 abstract 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 abstract 1
- 229930006000 Sucrose Natural products 0.000 abstract 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 abstract 1
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 abstract 1
- 239000007788 liquid Substances 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 229950008882 polysorbate Drugs 0.000 abstract 1
- 229920000136 polysorbate Polymers 0.000 abstract 1
- 239000005720 sucrose Substances 0.000 abstract 1
Landscapes
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicinal Preparation (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US39028310P | 2010-10-06 | 2010-10-06 | |
| PCT/US2011/054856 WO2012047954A1 (en) | 2010-10-06 | 2011-10-05 | Stabilized formulations containing anti-interleukin-4 receptor (il-4r) antibodies |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| UA111731C2 true UA111731C2 (uk) | 2016-06-10 |
Family
ID=45995014
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| UAA201305598A UA111731C2 (uk) | 2010-10-06 | 2011-05-10 | Стабілізована композиція, яка містить антитіло до рецептора інтерлейкіну-4 (іl-4r), варіанти |
Country Status (14)
| Country | Link |
|---|---|
| AR (1) | AR083338A1 (lt) |
| DK (2) | DK2624865T3 (lt) |
| ES (2) | ES2820246T3 (lt) |
| HK (1) | HK1258305A1 (lt) |
| HR (1) | HRP20181822T1 (lt) |
| HU (1) | HUE052089T2 (lt) |
| LT (1) | LT2624865T (lt) |
| PT (1) | PT3354280T (lt) |
| RS (1) | RS57850B1 (lt) |
| SI (1) | SI2624865T1 (lt) |
| SM (1) | SMT201800488T1 (lt) |
| TW (7) | TWI498121B (lt) |
| UA (1) | UA111731C2 (lt) |
| UY (1) | UY33652A (lt) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BR112015003590A8 (pt) | 2012-08-21 | 2017-10-31 | Sanofi Sa | Métodos para tratamento ou prevenção da asma por administração de um antagonista de il-4r |
| HUE046410T2 (hu) * | 2013-06-21 | 2020-03-30 | Sanofi Biotechnology | Eljárások orrpolipózis kezelésére IL-4R-antagonista beadásával |
| AU2014284235B2 (en) * | 2013-06-21 | 2019-11-21 | Regeneron Pharmaceuticals, Inc. | Methods for treating nasal polyposis by administering an IL-4R antagonist |
| WO2016077675A1 (en) | 2014-11-14 | 2016-05-19 | Sanofi Biotechnology | Methods for treating chronic sinusitis with nasal polyps by administering an il-4r antagonist |
| PL3703818T3 (pl) | 2017-10-30 | 2024-03-25 | Sanofi Biotechnology | Antagonista IL-4R do zastosowania w sposobie leczenia lub zapobiegania astmie |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7608693B2 (en) * | 2006-10-02 | 2009-10-27 | Regeneron Pharmaceuticals, Inc. | High affinity human antibodies to human IL-4 receptor |
| ES2332082B1 (es) * | 2008-07-24 | 2010-10-26 | Consejo Superior De Investigaciones Cientificas (Csic) 45% | Sistema de alineacion de patrones en un sustrato mediante litografia por estencil. |
| KR101593726B1 (ko) * | 2008-09-10 | 2016-02-18 | 니혼 엑스란 고교 (주) | 가교 아크릴레이트계 섬유 및 이의 제조방법 |
| CA2754528A1 (en) * | 2009-03-06 | 2010-09-10 | Genetech, Inc. | Antibody formulation |
-
2011
- 2011-05-10 UA UAA201305598A patent/UA111731C2/uk unknown
- 2011-10-03 AR ARP110103663 patent/AR083338A1/es not_active Application Discontinuation
- 2011-10-05 TW TW100135992A patent/TWI498121B/zh active
- 2011-10-05 ES ES18161288T patent/ES2820246T3/es active Active
- 2011-10-05 TW TW109131629A patent/TWI782325B/zh active
- 2011-10-05 TW TW105134483A patent/TWI679988B/zh active
- 2011-10-05 TW TW109107375A patent/TWI718890B/zh active
- 2011-10-05 RS RS20181308A patent/RS57850B1/sr unknown
- 2011-10-05 TW TW111138434A patent/TWI856388B/zh active
- 2011-10-05 DK DK11770625.9T patent/DK2624865T3/en active
- 2011-10-05 SM SM20180488T patent/SMT201800488T1/it unknown
- 2011-10-05 TW TW104123984A patent/TWI568445B/zh active
- 2011-10-05 LT LTEP11770625.9T patent/LT2624865T/lt unknown
- 2011-10-05 TW TW108111631A patent/TWI690329B/zh active
- 2011-10-05 HU HUE18161288A patent/HUE052089T2/hu unknown
- 2011-10-05 PT PT181612888T patent/PT3354280T/pt unknown
- 2011-10-05 DK DK18161288.8T patent/DK3354280T3/da active
- 2011-10-05 ES ES11770625.9T patent/ES2687813T3/es active Active
- 2011-10-05 SI SI201131568T patent/SI2624865T1/sl unknown
- 2011-10-06 UY UY33652A patent/UY33652A/es unknown
-
2018
- 2018-10-31 HR HRP20181822TT patent/HRP20181822T1/hr unknown
-
2019
- 2019-01-15 HK HK19100671.5A patent/HK1258305A1/zh unknown
Also Published As
| Publication number | Publication date |
|---|---|
| HK1258305A1 (zh) | 2019-11-08 |
| TW201716086A (zh) | 2017-05-16 |
| TW202320851A (zh) | 2023-06-01 |
| PT3354280T (pt) | 2020-09-01 |
| HUE052089T2 (hu) | 2021-04-28 |
| DK3354280T3 (da) | 2020-09-28 |
| SMT201800488T1 (it) | 2018-11-09 |
| TW202026011A (zh) | 2020-07-16 |
| TWI690329B (zh) | 2020-04-11 |
| TW202102262A (zh) | 2021-01-16 |
| UY33652A (es) | 2012-04-30 |
| TWI856388B (zh) | 2024-09-21 |
| TW201221141A (en) | 2012-06-01 |
| RS57850B1 (sr) | 2018-12-31 |
| ES2687813T3 (es) | 2018-10-29 |
| HRP20181822T1 (hr) | 2018-12-28 |
| ES2820246T3 (es) | 2021-04-20 |
| TWI718890B (zh) | 2021-02-11 |
| TW201542229A (zh) | 2015-11-16 |
| TWI498121B (zh) | 2015-09-01 |
| TWI782325B (zh) | 2022-11-01 |
| SI2624865T1 (sl) | 2018-10-30 |
| TWI679988B (zh) | 2019-12-21 |
| DK2624865T3 (en) | 2018-10-22 |
| TW201924718A (zh) | 2019-07-01 |
| AR083338A1 (es) | 2013-02-21 |
| LT2624865T (lt) | 2018-10-25 |
| TWI568445B (zh) | 2017-02-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NZ609557A (en) | Stabilized formulations containing anti-interleukin-4 receptor (il-4r) antibodies | |
| UA107211C2 (uk) | Стабілізовані склади, які містять антитіла до рецептора інтерлейкіну 6 (il-6r) | |
| NZ627859A (en) | Stabilized formulations containing anti-ang2 antibodies | |
| NZ705178A (en) | Anti-prolactin receptor antibody formulations | |
| UA111825C2 (uk) | Стабілізований препарат, що містить антитіло проти ngf | |
| TR201909663T4 (tr) | Formil peptit reseptör benzeri-1 (fprl-1) reseptör modülatörleri olarak 2,5-dioksoimidazolidin-1-il-3-fenilüre türevleri. | |
| WO2008121615A3 (en) | Antibody formulation | |
| NZ719036A (en) | Anti-pdl1 antibody formulations | |
| NZ629204A (en) | Anti-vla1 (cd49a) antibody pharmaceutical compositions | |
| PE20241623A1 (es) | Optimizacion de anticuerpos que se fijan al gen de activacion de linfocitos 3 (lag-3) y usos de los mismos | |
| UA116189C2 (uk) | КОМПОЗИЦІЯ АНТИ-α4β7 АНТИТІЛА | |
| NZ601374A (en) | Stabilized antibody-containing liquid formulations | |
| EA201000018A1 (ru) | Лиофилизированные лекарственные формы иммуноглобулинов и способы их получения | |
| PE20141028A1 (es) | Nuevos moduladores y metodos para su uso | |
| EA201170396A1 (ru) | 2-оксо-1,2-дигидрохинолиновые модуляторы иммунной функции | |
| FI3683235T3 (fi) | Anti-IL-33-vasta-aineita ja niiden käyttöjä | |
| RU2014140137A (ru) | Лекарственный препарат антитела к бета-амилоиду | |
| MX356337B (es) | Anticuerpos contra csf-1r humano y sus usos. | |
| EA201390669A1 (ru) | Способы и композиции для иммунотерапии заболеваний нервной системы | |
| UA111731C2 (uk) | Стабілізована композиція, яка містить антитіло до рецептора інтерлейкіну-4 (іl-4r), варіанти | |
| EA201390467A1 (ru) | Композиции антител и способы применения | |
| AR092325A1 (es) | Formulaciones estabilizadas que contienen anticuerpos anti-dll4 y kit | |
| MX347955B (es) | Novedoso anticuerpo anti-receptor de il-23 humano. | |
| EA202090016A3 (ru) | Стабилизированные композиции, содержащие антитела к рецептору интерлейкина-4 (il-4r) |